Zhang Junli, Li Changzheng, Ma Pengfei, Cao Yanghui, Włodarczyk Janusz, Ibrahim Mohsen, Liu Chenyu, Li Sen, Zhang Xijie, Han Guangsen, Zhao Yuzhou
Department of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Department of Thoracic and Surgical Oncology, Jagiellonian University Medical College, John Paul II Hospital, Cracow, Poland.
J Gastrointest Oncol. 2024 Feb 29;15(1):12-21. doi: 10.21037/jgo-23-968. Epub 2024 Feb 4.
At present, anastomotic fistula cannot be avoided after adenocarcinoma of the esophagogastric junction (AEG). Once the anastomotic leakage occurs, the posterior mediastinum and the left thoracic cavity are often seriously infected, which further impairs respiratory and circulatory function, heightening the danger of the disease course. The aim of this study was to identify the characteristics of superior anastomotic leakage after surgery for AEG and recommend corresponding treatment strategies to improve the diagnosis and treatment of superior anastomotic leakage after surgery for AEG.
The clinical data of 57 patients with superior anastomotic leakage after surgery for AEG in the Affiliated Cancer Hospital of Zhengzhou University from January 2017 to March 2019 were retrospectively analyzed, including 27 cases referred from external hospitals and 30 cases at the Affiliated Cancer Hospital of Zhengzhou University. According to the diameter and risk level of anastomotic leakage, the high anastomotic leakage is divided into types I, II, III, and IV.
Patients with preoperative comorbidities or those treated with the transabdominal approach or laparoscopic surgery often had type I and type II anastomotic leakage; meanwhile, patients with preoperative comorbidities and sacral perforation or those treated with a thoracic and abdominal approach or open surgery often had type III and IV fistula. The difference between types I-II and types III-IV was statistically significant (P<0.05). The mortality rate of patients with type III and type IV leakage was 14.8% within 90 days after operation, while no deaths occurred among patients with type I and type II leakage, and the difference in mortality between the two groups was statistically significant (P<0.05).
After surgery for AEG, suitable treatment measures should be adopted according to the type of superior anastomotic leakage that occurs. Types III and IV superior anastomotic leakages are associated with higher mortality and require greater attention from surgeons.
目前,食管胃交界腺癌(AEG)术后吻合口瘘难以避免。一旦发生吻合口漏,后纵隔和左胸腔常发生严重感染,进而损害呼吸和循环功能,增加病程危险性。本研究旨在明确AEG术后高位吻合口漏的特点,并推荐相应治疗策略,以提高AEG术后高位吻合口漏的诊治水平。
回顾性分析2017年1月至2019年3月郑州大学附属肿瘤医院57例AEG术后高位吻合口漏患者的临床资料,其中外院转入27例,郑州大学附属肿瘤医院30例。根据吻合口漏的直径和风险程度,将高位吻合口漏分为Ⅰ、Ⅱ、Ⅲ、Ⅳ型。
术前合并症患者或经腹入路或腹腔镜手术患者常发生Ⅰ型和Ⅱ型吻合口漏;同时,术前合并症且有骶骨穿孔患者或经胸腹部入路或开放手术患者常发生Ⅲ型和Ⅳ型瘘。Ⅰ - Ⅱ型与Ⅲ - Ⅳ型之间差异有统计学意义(P<0.05)。Ⅲ型和Ⅳ型漏患者术后90天内死亡率为14.8%,而Ⅰ型和Ⅱ型漏患者无死亡病例,两组死亡率差异有统计学意义(P<0.05)。
AEG术后,应根据发生的高位吻合口漏类型采取合适的治疗措施。Ⅲ型和Ⅳ型高位吻合口漏死亡率较高,需要外科医生给予更多关注。